UPC_CFI_2221/2025

ANTIGEN BINDING PROTEINS TO PROPROTEIN CONVERTASE SUBTILISIN KEXIN TYPE 9 (PCSK9)

OtherGenericMunich CDGenericWritten Phase

Overview Decisions Documents Timeline

Parties

Claimants

Amgen Inc.(Amgen Group)

Respondents

Regeneron Pharmaceuticals Inc.

Judges

Andras Kupecz

Patents

EP3666797

CPC codes: C07K2317/14, C07K2317/34, A61K39/395, A61K2039/505, A61K31/366, A61P3/06, A61K31/66, A61K31/22, A61P9/00, A61P7/00, A61P25/28, A61K2300/00…

Sector: Biotechnology

Outcome

—

Filed: Dec 23, 2025

First decided: —

Language: English

Open on UPC Registry